Litcius/Paper detail

Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cervical intraepithelial neoplasia lesions in women undergoing lesion surgical treatment (VACCIN): a multicentre, phase 4 randomised placebo-controlled trial in the Netherlands

Ralf L O van de Laar, Ward Hofhuis, Ruben G. Duijnhoven, Ruud L.M. Bekkers, H.P.M. Smedts, Gatske M. Nieuwenhuyzen-de Boer, Heleen J. van Beekhuizen, Angèle L.M. Oei, Annechien Bouman, Jojanneke van de Swaluw, Marchien van Baal, Sabrina Van Den Tillaart, Arnold‐Jan Kruse, Brenda Pijlman, Banut S. M. Verbruggen, David ten Cate, Rafli van de Laar, M.J.A. Engelen, Rafli van de Laar, M.J.A. Engelen

2025The Lancet Obstetrics Gynaecology & Women s Health11 citationsDOI

Topics & Concepts

MedicineHuman papillomavirusCervical intraepithelial neoplasiaAdjuvantInternal medicineVaccinationSurgeryClinical trialProphylactic treatmentIntraepithelial neoplasiaGynecologyRandomized controlled trialOncologyLesionCervical cancerDiseaseUterine cervixIncidence (geometry)PapillomaviridaeHPV vaccinesHuman papilloma virusYoung adultKoilocyteCervical Cancer and HPV ResearchGenital Health and DiseaseAI in cancer detection